ESC Premium Access

Prevalence, clinical features, and prognosis of patients with extremely low high-density lipoprotein cholesterol

Congress Presentation

About the speaker

Doctor Hayato Tada

Kanazawa University, Kanazawa (Japan)
2 presentations
0 follower

8 more presentations in this session

Reducing low density lipoprotein cholesterol (LDL-C) in homozygous familial hypercholesterolemia (HoFH) with a microsomal triglyceride transfer protein (MTP) inhibitor may reduce CV events

Speaker: Doctor H. Phillips (Shrewsbury, GB)


Antioxidant property of high-density lipoprotein predicts the presence of atherosclerotic cardiovascular disease and corneal arcus in patients with familial hypercholesterolemia

Speaker: Doctor M. Ogura (Urayasu, JP)


Lp(a) levels predict cardiovascular events in patients with Familial Hypercholesterolemia but not in unaffected relatives. SAFEHEART registry results.

Speaker: Doctor L. Perez De Isla (Madrid, ES)


Familial hypercholesterolaemia diagnosis: a case of missed opportunity

Speaker: Professor K. Ray (London, GB)


Whole exome sequencing in primary severe hypertriglyceridemia

Speaker: Doctor H. Tada (Kanazawa, JP)


Access the full session

What's new in hereditary dyslipidaemia?

Speakers: Doctor H. Tada, Doctor H. Phillips, Doctor M. Ogura, Doctor L. Perez De Isla, Professor K. Ray...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb